EVENT

Crinetics Reviews CRN04777 Phase 1 Single-ascending Dose Results

September 8, 2021

Event Details

Start Date: September 15, 2021 — 1:30 PM ET

End Date: September 15, 2021 — 2:30 PM ET

PRESENTATION

Crinetics management will discuss the preliminary findings from the single ascending dose cohorts from the Phase 1 clinical study of CRN04777 that were reported today.

Click here for live webcast

Download materials

Transforming Endocrine Disease Treatment

Be the first to know about the advances we're making in endocrine care.

EVENT

Crinetics Reviews CRN04777 Phase 1 Single-ascending Dose Results

Event Details

Transforming Endocrine Disease Treatment

Email Signup